Use of proton pump inhibitors in general practice

Figure 1 Subgroups of the population of the study divided according the use of proton pump inhibitors and the conditions for refund established by the Italian Drug Agency. ¹For the prevention of gastric damage of NSAIDS. Grey: PPI-users with refundable drug according the Italian Drug Agency because of protection of gastric damage by NSAIDS (4.5%); Black: PPI-users without identifiable refundable drug (4.6%); Dark Grey: Non PPI-users with identifiable need of the protection of gastric damage by NSAIDS (5.2%); White: The remaining population (85.7%); PPI: Proton pump inhibitors; NSAIDS: Non steroid inflammatory drugs.